Pouchitis Treatment Market By Treatment (Antibiotics, Probiotics, Others) By Route of Administration (Oral, Parenteral, Others) By End-User(Hospitals, Specialty Clinics, Others) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) – Growth, Future Prospects, and Competitive Analysis, 2016 – 2028

About this report

The Global Pouchitis Treatment Market report explores the critical analysis of the Pouchitis Treatment industry using key parameters. The report consists of investment strategies, the need for investments in the Pouchitis Treatment industry, and the multiple benefits for the investors. Importantly, this report sets out major changes in the global technical regulations for the Pouchitis Treatment industry, as well as how economic and non-economic barriers are helping the Pouchitis Treatment market. Moreover, the report analyses the global, regional, and country-level historic and forecasted market size. The report also provides a comprehensive analysis of key investment propositions, demand and supply gap, competitors positioning, STAR analysis, SRC analysis, and Tornado analysis. Key technological developments and other analyses such as porter’s five forces analysis, PESTEL analysis, value chain analysis, etc.

Key Highlights of the report

How are the major segments performing in the Pouchitis Treatment Market?

• In 2021, antibiotics will be the leading segment used to treat or prevent bacterial infections of this kind.
• In 2021, the oral segment will lead the market because the oral route is the most practical, frequently the safest, and frequently the least expensive.
• In 2021, the hospital’s segment will lead the market. The category is anticipated to grow fast during the projection due to rising disposable income and health concerns.
• In 2021, the hospital pharmacy segment in the application will lead the market because there will be more hospital pharmacies than in the past.

Which region dominated the Pouchitis Treatment Market?

In 2021, North America was one of the major contributors to the global pouchitis treatment market due to increased pouchitis cases and high healthcare expenditures. People in this region place a premium on high-quality healthcare, contributing to increased healthcare spending. Because pouchitis is becoming more common, numerous businesses, private groups, and government agencies are attempting to improve treatment choices. The market for pouchitis in the Americas is propelled by extensive research into the inflammatory bowel condition (IBD).

What is the competitive environment of the Pouchitis Treatment Market?

There will be more attractive market expansion potential as personal disposable income rises and awareness of the availability of treatment options in developing economies grows. The pouchitis treatment market is expanding due to rising R&D spending, intense continuous research on intestinal problems, and well-established healthcare infrastructure. For instance, in February 2019, the Janssen Pharmaceutical Companies of Johnson & Johnson received FDA approval for TREMFYA® One-Press, a single-dose, patient-controlled injector for adults.

Executive Summary

What are the various elements that contribute to the development of Pouchitis?

Pouchitis is a pouch-related inflammatory illness. It appears in the pouch lining during surgery to treat ulcerative colitis or another type of colitis disease. The typical symptoms include fecal incontinence, fever, diarrhea, abdominal pain, joint pain, and cramps. Therefore, the medical method known as pouchitis therapy” is used to treat these symptoms and cure the illness. Pouchitis affects almost half of those who have this operation at least once in their lifetime. Up to 40% of IPAA surgery patients experience pouchitis each year. Pouchitis has been found to occur in people with ulcerative or other colitis and infrequently in patients with familial adenomatous polyposis. This genetic disorder causes several colonic polyps to grow. Backwash ileitis, prolonged use of non-steroidal anti-inflammatory medicines (NSAIDs), an increase in platelets, smoking, and medical disorders, including diabetes or heart disease, are additional causes of pouchitis. Tenesmus, straining during bowel movements, blood in the stool, seepage of waste as you sleep, incontinence, tailbone discomfort, abdominal cramps, and an increase in the frequency of nighttime bowel movements are all typical signs of pouchitis.

Which are the key investments by the players in the Pouchitis Treatment Industry Market?

The market’s growth rate is significantly influenced by the increase in healthcare spending and investments, which aid in developing the market’s infrastructure. The healthcare sector’s growth, particularly in emerging nations, would encourage the use and application of cutting-edge medical tools, technology, and medications. The need for pouchitis treatment will consequently rise. For instance, in October 2018, AMGEVITA, the first Biosimilar Adalimumab, was introduced by Amgen for the treatment of moderate-to-severe illnesses. Pharmaceutical Company Limited by Takeda AstraZeneca, Pfizer, Inc., GlaxoSmithKline PLC, Boehringer Ingelheim GmbH, and other companies are working to develop possible medications to treat pouchitis more effectively.

Some of the prominent players in the pouchitis treatment market are AstraZeneca, Teva Pharmaceutical Industries Ltd., Sebela Pharmaceuticals, Inc., Novartis AG, Pfizer Inc., Strides Pharma Science Limited., Tolmar Pharmaceuticals, Inc., Synergy Pharmaceuticals, Inc., LUPIN., Bausch Health., Sanofi, Synergy Pharmaceuticals, Atlantic Healthcare, Abbott, Takeda Pharmaceutical Company Limited, Ironwood Pharmaceuticals, Inc., Cipla Inc., Novartis AG and Glenmark Pharmaceuticals Ltd.

What are the Major Driving Factors for the Pouchitis Treatment Market?

The rising prevalence of inflammation in patients or inflammatory disorders drives the demand for appropriate medical treatment. Inflammatory illnesses include fatty liver, asthma, atopic dermatitis, Crohn’s disease, and psoriasis. Furthermore, individuals’ unhealthy lifestyles, rising activities by public and private groups to raise awareness, and increased tobacco consumption are factors that will accelerate market expansion. Other factors, such as increased demand for effective medicines and early diagnostic methods, will benefit the market’s growth rate. Increased personal disposable income and increased awareness in developing economies about the availability of treatment options will provide even more attractive market growth potential.

What are the Major Risks for the Pouchitis Treatment Market?

One of the main market barriers will be the high expenses associated with research and development expertise. The Food and Drug Administration’s (FDA) strict rules, a lack of awareness and the necessary infrastructure in underdeveloped and backward nations, and unfavorable conditions brought on by the COVID-19 outbreak will all hinder market expansion. The slow drug and inhibitor approval rate, the negative side effects of current treatments, and the rising number of patent expiration cases will challenge the market’s growth rate.

Which is the Key Sales Channel in the Pouchitis Treatment Market?

In 2021, the antibiotic segment dominated the pouchitis market. Antibiotics, commonly referred to as antibacterial, are drugs that stop or inhibit the growth of germs. They are used to treat illnesses brought on by germs and comprise a variety of potent medications. Modern antibiotics come in various forms, but in most nations, they can only be obtained with a prescription. Antibiotics, budesonide enemas, probiotics, glutamine and butyrate suppositories, bismuth enemas, allopurinol, and tinidazole are some of the current treatment options for pouchitis. With the introduction of foreign substances like bacteria and viruses into the body, plasma cells create antibodies, which are glycoprotein molecules. An essential role of the immune system is the generation of antibodies.

How is the Pouchitis Treatment Market performing in regions?

In 2021, the global pouchitis treatment market was dominated by North America because of an increase in pouchitis occurrences and hefty healthcare costs. People in this region value great healthcare, which contributes to an increase in healthcare spending. Because of the increasing prevalence of pouchitis, many firms, private groups, and government agencies are working to enhance treatment options. The market for pouchitis in the Americas is being driven by substantial ongoing research on inflammatory bowel disease (IBD). Takeda Pharmaceuticals research scholar awards in IBD and Pfizer pilot research awards in IBD have been launched by the American Gastroenterological Association (AGA) to encourage investigators studying inflammatory bowel disease (IBD).

Besides, the Asia-Pacific region is expected to grow significantly over the forecast period because of increased pouchitis prevalence and increased investment by pouchitis treatment market participants in these regions. India and China are driving growth because of their vast patient bases undergoing ileal pouch-anal anastomosis; their higher incidence of ulcerative colitis; increased disease awareness; increased government activities toward healthcare; and the development of healthcare infrastructure.

What is the regulatory landscape for the Pouchitis Treatment Market?

Increased government support for market research and development initiatives and increased demand from emerging nations will generate new prospects for the pouchitis treatment market. This year, global health tech has attracted $51.3 billion in funding. The biggest substantial increase was found in the United Kingdom, where health tech investment has increased ninefold (with U.S. investment increasing by 3.4 times).

What is the Market Size of the Pouchitis Treatment regarding value?

The Pouchitis Treatment Market is anticipated to grow at a substantial CAGR of 10.40% in the upcoming years. The Global Pouchitis Treatment industry was estimated to be worth USD 63.5 million in 2021 and was expected to be worth USD 114.9 million by 2028.

What are the major players planning for the future of the Pouchitis Treatment Market?

Rising medical tourism globally increased the availability of low-cost pharmaceuticals, and a high potential for growth in the undeveloped market would provide enough market growth possibilities. The market’s growth will be boosted by increased awareness about treatment, technological advancement, and rapid adoption of innovative formulations and novel dosage forms, among other factors driving the Pouchitis Treatment Market.

Segmentation of Global Pouchitis Treatment Market-

Global Pouchitis Treatment Market – By Treatment 

• Antibiotics
• Probiotics
• Others

Global Pouchitis Treatment Market – By Route of Administration

• Oral
• Parenteral
• Others

Global Pouchitis Treatment Market – By End-User 

• Hospitals
• Specialty Clinics
• Others

Global Pouchitis Treatment Market – By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Others

Global Pouchitis Treatment Market – By Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • South-east Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Segmentation

2. Executive Summary
2.1. Market Snapshot: Global Pouchitis Treatment Market
2.2. Global Pouchitis Treatment Market, By Treatment
2.3. Global Pouchitis Treatment Market, By Route of Administration
2.4. Global Pouchitis Treatment Market, By End User
2.5. Global Pouchitis Treatment Market, By Distribution Channel
2.6. Global Pouchitis Treatment Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Pouchitis Treatment Market Value, 2016-2028, (US$ Bn)
3.2. Market Dynamics
3.2.1. Key Growth Trends
3.2.2. Market Drivers
3.2.3. Market Restraints
3.2.4. Market Opportunities
3.2.5. Major Industry Challenges
3.3. Attractive Investment Proposition,2021
3.3.1. Treatment
3.3.2. Route of Administration
3.3.3. End User
3.3.4. Distribution Channel
3.3.5. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Value Chain Analysis
4.4. Technology Analysis
4.5. Marketing Strategy Analysis
4.5.1. Direct Marketing
4.5.2. Indirect Marketing
4.5.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2021
5.1. Company market share of key players, 2021
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. COVID 19 Impact Analysis
6.1. Global Pouchitis Treatment Market Pre Vs Post COVID 19, 2019 – 2028
6.2. Impact on Import & Export
6.3. Impact on Demand & Supply

7. Global Pouchitis Treatment Market
7.1. Global Pouchitis Treatment Market, by Treatment, 2016-2028(US$ Bn)
7.1.1. Overview
7.1.2. Global Pouchitis Treatment Market, By Treatment, 2021 vs 2028 (in%)
7.1.3. Global Pouchitis Treatment Market, By Antibiotics, 2016-2028 (US$ Bn)
7.1.4. Global Pouchitis Treatment Market, By Probiotics, 2016-2028 (US$ Bn)
7.1.5. Global Pouchitis Treatment Market, By Others, 2016-2028 (US$ Bn)
7.2. Global Pouchitis Treatment Market, by Route of Administration, 2016-2028(US$ Bn)
7.2.1. Overview
7.2.2. Global Pouchitis Treatment Market, By Route of Administration, 2021 vs 2028 (in%)
7.2.3. Global Pouchitis Treatment Market, By Oral, 2016-2028 (US$ Bn)
7.2.4. Global Pouchitis Treatment Market, By Parenteral, 2016-2028 (US$ Bn)
7.2.5. Global Pouchitis Treatment Market, By Others, 2016-2028 (US$ Bn)
7.3. Global Pouchitis Treatment Market, by End User, 2016-2028(US$ Bn)
7.3.1. Overview
7.3.2. Global Pouchitis Treatment Market, By End User, 2021 vs 2028 (in%)
7.3.3. Global Pouchitis Treatment Market, By Hospitals, 2016-2028 (US$ Bn)
7.3.4. Global Pouchitis Treatment Market, By Specialty Clinics, 2016-2028 (US$ Bn)
7.3.5. Global Pouchitis Treatment Market, By Others, 2016-2028 (US$ Bn)
7.4. Global Pouchitis Treatment Market, by Distribution Channel, 2016-2028(US$ Bn)
7.4.1. Overview
7.4.2. Global Pouchitis Treatment Market, By Distribution Channel, 2021 vs 2028 (in%)
7.4.3. Global Pouchitis Treatment Market, By Hospital Pharmacy, 2016-2028 (US$ Bn)
7.4.4. Global Pouchitis Treatment Market, By Retail Pharmacy, 2016-2028 (US$ Bn)
7.4.5. Global Pouchitis Treatment Market, By Others, 2016-2028 (US$ Bn)

8. North America Pouchitis Treatment Market Analysis
8.1. North America Pouchitis Treatment Market, by Treatment, 2016-2028(US$ Bn)
8.1.1. Overview
8.1.2. SRC Analysis
8.2. North America Pouchitis Treatment Market, by Route of Administration, 2016-2028(US$ Bn)
8.2.1. Overview
8.2.2. SRC Analysis
8.3. North America Pouchitis Treatment Market, by End User, 2016-2028(US$ Bn)
8.3.1. Overview
8.3.2. SRC Analysis
8.4. North America Pouchitis Treatment Market, by Distribution Channel, 2016-2028(US$ Bn)
8.4.1. Overview
8.4.2. SRC Analysis
8.5. North America Pouchitis Treatment Market, by Country, 2016-2028 (US$ Bn)
8.5.1. U.S.
8.5.1.1. U.S. Pouchitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
8.5.1.2. U.S. Pouchitis Treatment, By Treatment, 2016-2028 (US$ Bn)
8.5.1.3. U.S. Pouchitis Treatment, By Route of Administration, 2016-2028 (US$ Bn)
8.5.1.4. U.S. Pouchitis Treatment, By End User, 2016-2028 (US$ Bn)
8.5.1.5. U.S. Pouchitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)
8.5.2. Canada
8.5.2.1. Canada Pouchitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
8.5.2.2. Canada Pouchitis Treatment, By Treatment, 2016-2028 (US$ Bn)
8.5.2.3. Canada Pouchitis Treatment, By Route of Administration, 2016-2028 (US$ Bn)
8.5.2.4. Canada Pouchitis Treatment, By End User, 2016-2028 (US$ Bn)
8.5.2.5. Canada Pouchitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)

9. Europe Pouchitis Treatment Market Analysis
9.1. Europe Pouchitis Treatment Market, by Treatment, 2016-2028(US$ Bn)
9.1.1. Overview
9.1.2. SRC Analysis
9.2. Europe Pouchitis Treatment Market, by Route of Administration, 2016-2028(US$ Bn)
9.2.1. Overview
9.2.2. SRC Analysis
9.3. Europe Pouchitis Treatment Market, by End User, 2016-2028(US$ Bn)
9.3.1. Overview
9.3.2. SRC Analysis
9.4. Europe Pouchitis Treatment Market, by Distribution Channel, 2016-2028(US$ Bn)
9.4.1. Overview
9.4.2. SRC Analysis
9.5. Europe Pouchitis Treatment Market, by Country, 2016-2028 (US$ Bn)
9.5.1. Germany
9.5.1.1. Germany Pouchitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.5.1.2. Germany Pouchitis Treatment, By Treatment, 2016-2028 (US$ Bn)
9.5.1.3. Germany Pouchitis Treatment, By Route of Administration, 2016-2028 (US$ Bn)
9.5.1.4. Germany Pouchitis Treatment, By End User, 2016-2028 (US$ Bn)
9.5.1.5. Germany Pouchitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)
9.5.2. France
9.5.2.1. France Pouchitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.5.2.2. France Pouchitis Treatment, By Treatment, 2016-2028 (US$ Bn)
9.5.2.3. France Pouchitis Treatment, By Route of Administration, 2016-2028 (US$ Bn)
9.5.2.4. France Pouchitis Treatment, By End User, 2016-2028 (US$ Bn)
9.5.2.5. France Pouchitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)
9.5.3. UK
9.5.3.1. UK Pouchitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.5.3.2. UK Pouchitis Treatment, By Treatment, 2016-2028 (US$ Bn)
9.5.3.3. UK Pouchitis Treatment, By Route of Administration, 2016-2028 (US$ Bn)
9.5.3.4. UK Pouchitis Treatment, By End User, 2016-2028 (US$ Bn)
9.5.3.5. U.K. Pouchitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)
9.5.4. Italy
9.5.4.1. Italy Pouchitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.5.4.2. Italy Pouchitis Treatment, By Treatment, 2016-2028 (US$ Bn)
9.5.4.3. Italy Pouchitis Treatment, By Route of Administration, 2016-2028 (US$ Bn)
9.5.4.4. Italy Pouchitis Treatment, By End User, 2016-2028 (US$ Bn)
9.5.4.5. Italy Pouchitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)
9.5.5. Spain
9.5.5.1. Spain Pouchitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.5.5.2. Spain Pouchitis Treatment, By Treatment, 2016-2028 (US$ Bn)
9.5.5.3. Spain Pouchitis Treatment, By Route of Administration, 2016-2028 (US$ Bn)
9.5.5.4. Spain Pouchitis Treatment, By End User, 2016-2028 (US$ Bn)
9.5.5.5. Spain Pouchitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)
9.5.6. Rest of Europe
9.5.6.1. Rest of Europe Pouchitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.5.6.2. Rest of Europe Pouchitis Treatment, By Treatment, 2016-2028 (US$ Bn)
9.5.6.3. Rest of Europe Pouchitis Treatment, By Route of Administration, 2016-2028 (US$ Bn)
9.5.6.4. Rest of Europe Pouchitis Treatment, By End User, 2016-2028 (US$ Bn)
9.5.6.5. Rest of Europe Pouchitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)

10. Asia Pacific Pouchitis Treatment Market Analysis
10.1. Asia Pacific Pouchitis Treatment Market, by Treatment, 2016-2028(US$ Bn)
10.1.1. Overview
10.1.2. SRC Analysis
10.2. Asia Pacific Pouchitis Treatment Market, by Route of Administration, 2016-2028(US$ Bn)
10.2.1. Overview
10.2.2. SRC Analysis
10.3. Asia Pacific Pouchitis Treatment Market, by End User, 2016-2028(US$ Bn)
10.3.1. Overview
10.3.2. SRC Analysis
10.4. Asia Pacific Pouchitis Treatment Market, by Distribution Channel, 2016-2028(US$ Bn)
10.4.1. Overview
10.4.2. SRC Analysis
10.5. Asia Pacific Pouchitis Treatment Market, by Country, 2016-2028 (US$ Bn)
10.5.1. China
10.5.1.1. China Pouchitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.5.1.2. China Pouchitis Treatment, By Treatment, 2016-2028 (US$ Bn)
10.5.1.3. China Pouchitis Treatment, By Route of Administration, 2016-2028 (US$ Bn)
10.5.1.4. China Pouchitis Treatment, By End User, 2016-2028 (US$ Bn)
10.5.1.5. China Pouchitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)
10.5.2. Japan
10.5.2.1. Japan Pouchitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.5.2.2. Japan Pouchitis Treatment, By Treatment, 2016-2028 (US$ Bn)
10.5.2.3. Japan Pouchitis Treatment, By Route of Administration, 2016-2028 (US$ Bn)
10.5.2.4. Japan Pouchitis Treatment, By End User, 2016-2028 (US$ Bn)
10.5.2.5. Japan Pouchitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)
10.5.3. India
10.5.3.1. India Pouchitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.5.3.2. India Pouchitis Treatment, By Treatment, 2016-2028 (US$ Bn)
10.5.3.3. India Pouchitis Treatment, By Route of Administration, 2016-2028 (US$ Bn)
10.5.3.4. India Pouchitis Treatment, By End User, 2016-2028 (US$ Bn)
10.5.3.5. India Pouchitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)
10.5.4. South Korea
10.5.4.1. South Korea Pouchitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.5.4.2. South Korea Pouchitis Treatment, By Treatment, 2016-2028 (US$ Bn)
10.5.4.3. South Korea Pouchitis Treatment, By Route of Administration, 2016-2028 (US$ Bn)
10.5.4.4. South Korea Pouchitis Treatment, By End User, 2016-2028 (US$ Bn)
10.5.4.5. South Korea Pouchitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)
10.5.5. South-East Asia
10.5.5.1. South-East Asia Pouchitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.5.5.2. South-East Asia Pouchitis Treatment, By Treatment, 2016-2028 (US$ Bn)
10.5.5.3. South-East Asia Pouchitis Treatment, By Route of Administration, 2016-2028 (US$ Bn)
10.5.5.4. South-East Asia Pouchitis Treatment, By End User, 2016-2028 (US$ Bn)
10.5.5.5. South-East Asia Pouchitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)
10.5.6. Rest of Asia Pacific
10.5.6.1. Rest of Asia Pacific Pouchitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.5.6.2. Rest of Asia Pacific Pouchitis Treatment, By Treatment, 2016-2028 (US$ Bn)
10.5.6.3. Rest of Asia Pacific Pouchitis Treatment, By Route of Administration, 2016-2028 (US$ Bn)
10.5.6.4. Rest of Asia Pacific Pouchitis Treatment, By End User, 2016-2028 (US$ Bn)
10.5.6.5. Rest of Asia Pacific Pouchitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)

11. Latin America Pouchitis Treatment Market Analysis
11.1. Latin America Pouchitis Treatment Market, by Treatment, 2016-2028(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. Latin America Pouchitis Treatment Market, by Route of Administration, 2016-2028(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. Latin America Pouchitis Treatment Market, by End User, 2016-2028(US$ Bn)
11.3.1. Overview
11.3.2. SRC Analysis
11.4. Latin America Pouchitis Treatment Market, by Distribution Channel, 2016-2028(US$ Bn)
11.4.1. Overview
11.4.2. SRC Analysis
11.5. Latin America Pouchitis Treatment Market, by Country, 2016-2028 (US$ Bn)
11.5.1. Brazil
11.5.1.1. Brazil Pouchitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.5.1.2. Brazil Pouchitis Treatment, By Treatment, 2016-2028 (US$ Bn)
11.5.1.3. Brazil Pouchitis Treatment, By Route of Administration, 2016-2028 (US$ Bn)
11.5.1.4. Brazil Pouchitis Treatment, By End User, 2016-2028 (US$ Bn)
11.5.1.5. Brazil Pouchitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)
11.5.2. Mexico
11.5.2.1. Mexico Pouchitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.5.2.2. Mexico Pouchitis Treatment, By Treatment, 2016-2028 (US$ Bn)
11.5.2.3. Mexico Pouchitis Treatment, By Route of Administration, 2016-2028 (US$ Bn)
11.5.2.4. Mexico Pouchitis Treatment, By End User, 2016-2028 (US$ Bn)
11.5.2.5. Mexico Pouchitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)
11.5.3. Rest of Latin America
11.5.3.1. Rest of Latin America Pouchitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.5.3.2. Rest of Latin America Pouchitis Treatment, By Treatment, 2016-2028 (US$ Bn)
11.5.3.3. Rest of Latin America Pouchitis Treatment, By Route of Administration, 2016-2028 (US$ Bn)
11.5.3.4. Rest of Latin America Pouchitis Treatment, By End User, 2016-2028 (US$ Bn)
11.5.3.5. Rest of Latin America Pouchitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)

12. Middle East and Africa Pouchitis Treatment Market Analysis
12.1. Middle East and Africa Pouchitis Treatment Market, by Treatment, 2016-2028(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Middle East and Africa Pouchitis Treatment Market, by Route of Administration, 2016-2028(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Middle East and Africa Pouchitis Treatment Market, by End User, 2016-2028(US$ Bn)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. Middle East and Africa Pouchitis Treatment Market, by Distribution Channel, 2016-2028(US$ Bn)
12.4.1. Overview
12.4.2. SRC Analysis
12.5. Middle East and Africa Pouchitis Treatment Market, by Country, 2016-2028 (US$ Bn)
12.5.1. GCC Countries
12.5.1.1. GCC Countries il Pouchitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
12.5.1.2. GCC Countries Pouchitis Treatment, By Treatment, 2016-2028 (US$ Bn)
12.5.1.3. GCC Countries Pouchitis Treatment, By Route of Administration, 2016-2028 (US$ Bn)
12.5.1.4. GCC Countries Pouchitis Treatment, By End User, 2016-2028 (US$ Bn)
12.5.1.5. GCC Countries Pouchitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)
12.5.2. South Africa
12.5.2.1. South Africa Pouchitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
12.5.2.2. South Africa Pouchitis Treatment, By Treatment, 2016-2028 (US$ Bn)
12.5.2.3. South Africa Pouchitis Treatment, By Route of Administration, 2016-2028 (US$ Bn)
12.5.2.4. South Africa Pouchitis Treatment, By End User, 2016-2028 (US$ Bn)
12.5.2.5. South Africa Pouchitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)
12.5.3. Rest of Middle East and Africa
12.5.3.1. Rest of Middle East and Africa Pouchitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
12.5.3.2. Rest of Middle East and Africa Pouchitis Treatment, By Treatment, 2016-2028 (US$ Bn)
12.5.3.3. Rest of Middle East and Africa Pouchitis Treatment, By Route of Administration, 2016-2028 (US$ Bn)
12.5.3.4. Rest of Middle East and Africa Pouchitis Treatment, By End User, 2016-2028 (US$ Bn)
12.5.3.5. Rest of Middle East and Africa Pouchitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)

13. Company Profiles
13.1. AstraZeneca
13.1.1. Company Overview
13.1.2. Products/Services Portfolio
13.1.3. Geographical Presence
13.1.4. Financial Summary
13.1.4.1. Market Revenue and Net Profit (2019-2021)
13.1.4.2. Business Segment Revenue Analysis
13.1.4.3. Geographical Revenue Analysis
13.2. Teva Pharmaceutical Industries Ltd.
13.3. Sebela
13.4. Pharmaceuticals, Inc.
13.5. Novartis AG
13.6. Pfizer Inc.
13.7. Strides Pharma Science Limited.
13.8. Tolmar Pharmaceuticals, Inc.
13.9. Synergy Pharmaceuticals, Inc.
13.10. LUPIN.
13.11. Bausch Health.
13.12. Sanofi
13.13. Synergy Pharmaceuticals
13.14. Atlantic Healthcare
13.15. Abbott
13.16. Takeda Pharmaceutical Company Limited
13.17. Ironwood Pharmaceuticals, Inc.
13.18. Cipla Inc.
13.19. Novartis AG
13.20. Glenmark Pharmaceuticals Ltd.

List of Figures

FIG. 1 Global Pouchitis Treatment Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Pouchitis Treatment Market Segmentation
FIG. 4 Global Pouchitis Treatment Market, by Treatment, 2021 (US$ Bn)
FIG. 5 Global Pouchitis Treatment Market, by Route of Administration, 2021 (US$ Bn)
FIG. 6 Global Pouchitis Treatment Market, by End User, 2021 (US$ Bn)
FIG. 7 Global Pouchitis Treatment Market, by Distribution Channel, 2021 (US$ Bn)
FIG. 8 Global Pouchitis Treatment Market, by Geography, 2021 (US$ Bn)
FIG. 9 Attractive Investment Proposition, by Treatment, 2021
FIG. 10 Attractive Investment Proposition, by Route of Administration, 2021
FIG. 11 Attractive Investment Proposition, by End User, 2021
FIG. 12 Attractive Investment Proposition, by Distribution Channel, 2021
FIG. 13 Attractive Investment Proposition, by Geography, 2021
FIG. 14 Global Market Share Analysis of Key Pouchitis Treatment Market Manufacturers, 2021
FIG. 15 Global Market Positioning of Key Pouchitis Treatment Market Manufacturers, 2021
FIG. 16 Global Pouchitis Treatment Market Value Contribution, By Treatment, 2021 & 2028 (Value %)
FIG. 17 Global Pouchitis Treatment Market, by Antibiotics, Value, 2016-2028 (US$ Bn)
FIG. 18 Global Pouchitis Treatment Market, by Probiotics, Value, 2016-2028 (US$ Bn)
FIG. 19 Global Pouchitis Treatment Market, by Others, Value, 2016-2028 (US$ Bn)
FIG. 20 Global Pouchitis Treatment Market Value Contribution, By Route of Administration, 2021 & 2028 (Value %)
FIG. 21 Global Pouchitis Treatment Market, by Oral, Value, 2016-2028 (US$ Bn)
FIG. 22 Global Pouchitis Treatment Market, by Parenteral, Value, 2016-2028 (US$ Bn)
FIG. 23 Global Pouchitis Treatment Market, by Others, Value, 2016-2028 (US$ Bn)
FIG. 24 Global Pouchitis Treatment Market Value Contribution, By End User, 2021 & 2028 (Value %)
FIG. 25 Global Pouchitis Treatment Market, by Hospitals, Value, 2016-2028 (US$ Bn)
FIG. 26 Global Pouchitis Treatment Market, by Specialty Clinics, Value, 2016-2028 (US$ Bn)
FIG. 27 Global Pouchitis Treatment Market, by Others, Value, 2016-2028 (US$ Bn)
FIG. 28 Global Pouchitis Treatment Market Value Contribution, By Distribution Channel, 2021 & 2028 (Value %)
FIG. 29 Global Pouchitis Treatment Market, by Hospital Pharmacy, Value, 2016-2028 (US$ Bn)
FIG. 30 Global Pouchitis Treatment Market, by Retail Pharmacy, Value, 2016-2028 (US$ Bn)
FIG. 31 Global Pouchitis Treatment Market, by Others, Value, 2016-2028 (US$ Bn)
FIG. 32 U.S. Pouchitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 33 Canada Pouchitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 34 Germany Pouchitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 35 France Pouchitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 36 U.K. Pouchitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 37 Italy Pouchitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 38 Spain Pouchitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 39 Rest of Europe Pouchitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 40 China Pouchitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 41 Japan Pouchitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 42 India Pouchitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 43 South Korea Pouchitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 44 Southeast Asia Pouchitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 45 Rest of Asia Pacific Pouchitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 46 Latin America Pouchitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 47 Brazil Pouchitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 48 Mexico Pouchitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 49 Rest of Latin America Pouchitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 50 Middle East & Africa Pouchitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 51 GCC Countries Pouchitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 52 South Africa Pouchitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 53 Rest of Middle East and Africa Pouchitis Treatment Market, 2016-2028 (US$ Bn)

List of Tables

TABLE 1 Market Snapshot: Global Pouchitis Treatment Market
TABLE 2 Global Pouchitis Treatment Market, by Competitive Benchmarking, 2021
TABLE 3 Global Pouchitis Treatment Market, by Geographical Presence Analysis, 2021
TABLE 4 Global Pouchitis Treatment Market, by Key Strategies Analysis, 2021
TABLE 5 Global Pouchitis Treatment Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 6 Global Pouchitis Treatment Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 7 Global Pouchitis Treatment Market, by End User, 2016-2028 (US$ Bn)
TABLE 8 Global Pouchitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 9 Global Pouchitis Treatment Market, by Geography, 2016-2028 (US$ Bn)
TABLE 10 North America Pouchitis Treatment Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 11 North America Pouchitis Treatment Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 12 North America Pouchitis Treatment Market, by End User, 2016-2028 (US$ Bn)
TABLE 13 North America Pouchitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 14 North America Pouchitis Treatment Market, by Country, 2016-2028 (US$ Bn)
TABLE 15 US Pouchitis Treatment Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 16 US Pouchitis Treatment Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 17 US Pouchitis Treatment Market, by End User, 2016-2028 (US$ Bn)
TABLE 18 US Pouchitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 19 Canada Pouchitis Treatment Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 20 Canada Pouchitis Treatment Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 21 Canada Pouchitis Treatment Market, by End User, 2016-2028 (US$ Bn)
TABLE 22 Canada Pouchitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 23 Europe Pouchitis Treatment Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 24 Europe Pouchitis Treatment Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 25 Europe Pouchitis Treatment Market, by End User, 2016-2028 (US$ Bn)
TABLE 26 Europe Pouchitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 27 Europe Pouchitis Treatment Market, by Country, 2016-2028 (US$ Bn)
TABLE 28 Germany Pouchitis Treatment Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 29 Germany Pouchitis Treatment Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 30 Germany Pouchitis Treatment Market, by End User, 2016-2028 (US$ Bn)
TABLE 31 Germany Pouchitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 32 France Pouchitis Treatment Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 33 France Pouchitis Treatment Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 34 France Pouchitis Treatment Market, by End User, 2016-2028 (US$ Bn)
TABLE 35 France Pouchitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 36 UK Pouchitis Treatment Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 37 UK Pouchitis Treatment Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 38 UK Pouchitis Treatment Market, by End User, 2016-2028 (US$ Bn)
TABLE 39 UK Pouchitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 40 Italy Pouchitis Treatment Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 41 Italy Pouchitis Treatment Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 42 Italy Pouchitis Treatment Market, by End User, 2016-2028 (US$ Bn)
TABLE 43 Italy Pouchitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 44 Spain Pouchitis Treatment Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 45 Spain Pouchitis Treatment Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 46 Spain Pouchitis Treatment Market, by End User, 2016-2028 (US$ Bn)
TABLE 47 Spain Pouchitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 48 Rest of Europe Pouchitis Treatment Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 49 Rest of Europe Pouchitis Treatment Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 50 Rest of Europe Pouchitis Treatment Market, by End User, 2016-2028 (US$ Bn)
TABLE 51 Rest of Europe Pouchitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 52 Asia Pacific Pouchitis Treatment Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 53 Asia Pacific Pouchitis Treatment Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 54 Asia Pacific Pouchitis Treatment Market, by End User, 2016-2028 (US$ Bn)
TABLE 55 Asia Pacific Pouchitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 56 Asia Pacific Pouchitis Treatment Market, by Country, 2016-2028 (US$ Bn)
TABLE 57 China Pouchitis Treatment Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 58 China Pouchitis Treatment Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 59 China Pouchitis Treatment Market, by End User, 2016-2028 (US$ Bn)
TABLE 60 China Pouchitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 61 Japan Pouchitis Treatment Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 62 Japan Pouchitis Treatment Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 63 Japan Pouchitis Treatment Market, by End User, 2016-2028 (US$ Bn)
TABLE 64 Japan Pouchitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 65 India Pouchitis Treatment Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 66 India Pouchitis Treatment Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 67 India Pouchitis Treatment Market, by End User, 2016-2028 (US$ Bn)
TABLE 68 India Pouchitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 69 South Korea Pouchitis Treatment Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 70 South Korea Pouchitis Treatment Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 71 South Korea Pouchitis Treatment Market, by End User, 2016-2028 (US$ Bn)
TABLE 72 South Korea Pouchitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 73 South East Asia Pouchitis Treatment Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 74 South East Asia Pouchitis Treatment Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 75 South East Asia Pouchitis Treatment Market, by End User, 2016-2028 (US$ Bn)
TABLE 76 South East Asia Pouchitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 77 Rest of Asia Pacific Pouchitis Treatment Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 78 Rest of Asia Pacific Pouchitis Treatment Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 79 Rest of Asia Pacific Pouchitis Treatment Market, by End User, 2016-2028 (US$ Bn)
TABLE 80 Rest of Asia Pacific Pouchitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 81 Latin America Pouchitis Treatment Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 82 Latin America Pouchitis Treatment Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 83 Latin America Pouchitis Treatment Market, by End User, 2016-2028 (US$ Bn)
TABLE 84 Latin America Pouchitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 85 Latin America Pouchitis Treatment Market, by Country, 2016-2028 (US$ Bn)
TABLE 86 Brazil Pouchitis Treatment Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 87 Brazil Pouchitis Treatment Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 88 Brazil Pouchitis Treatment Market, by End User, 2016-2028 (US$ Bn)
TABLE 89 Brazil Pouchitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 90 Mexico Pouchitis Treatment Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 91 Mexico Pouchitis Treatment Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 92 Mexico Pouchitis Treatment Market, by End User, 2016-2028 (US$ Bn)
TABLE 93 Mexico Pouchitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 94 Rest of Latin America Pouchitis Treatment Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 95 Rest of Latin America Pouchitis Treatment Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 96 Rest of Latin America Pouchitis Treatment Market, by End User, 2016-2028 (US$ Bn)
TABLE 97 Rest of Latin America Pouchitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 98 Middle East and Africa Pouchitis Treatment Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 99 Middle East and Africa Pouchitis Treatment Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 100 Middle East and Africa Pouchitis Treatment Market, by End User, 2016-2028 (US$ Bn)
TABLE 101 Middle East and Africa Pouchitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 102 Middle East and Africa Pouchitis Treatment Market, by Country, 2016-2028 (US$ Bn)
TABLE 103 GCC Countries Pouchitis Treatment Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 104 GCC Countries Pouchitis Treatment Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 105 GCC Countries Pouchitis Treatment Market, by End User, 2016-2028 (US$ Bn)
TABLE 106 GCC Countries Pouchitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 107 South Africa Pouchitis Treatment Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 108 South Africa Pouchitis Treatment Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 109 South Africa Pouchitis Treatment Market, by End User, 2016-2028 (US$ Bn)
TABLE 110 South Africa Pouchitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 111 Rest of Middle East and Africa Pouchitis Treatment Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 112 Rest of Middle East and Africa Pouchitis Treatment Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 113 Rest of Middle East and Africa Pouchitis Treatment Market, by End User, 2016-2028 (US$ Bn)
TABLE 114 Rest of Middle East and Africa Pouchitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)